Cargando…

Explant Modeling of the Immune Environment of Head and Neck Cancer

Patients exhibit distinct responses to immunotherapies that are thought to be linked to their tumor immune environment. However, wide variations in outcomes are also observed in patients with matched baseline tumor environments, indicating that the biological response to treatment is not currently p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharon, Shay, Duhen, Thomas, Bambina, Shelly, Baird, Jason, Leidner, Rom, Bell, Bryan, Casap, Nardy, Crittenden, Marka, Vasudevan, Swetha, Jubran, Maria, Kravchenko-Balasha, Nataly, Gough, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249923/ https://www.ncbi.nlm.nih.gov/pubmed/34221953 http://dx.doi.org/10.3389/fonc.2021.611365

Ejemplares similares

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection
por: Sharon, Shay, et al.
Publicado: (2021)

The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer
por: Sharon, Shay, et al.
Publicado: (2023)

Radiation therapy and vaccination against tumor-specific EGFRvIII effectively clears tumors in a murine model of head and neck squamous cell carcinoma
por: Uhde, Lauren, et al.
Publicado: (2015)

Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes
por: Duhen, Thomas, et al.
Publicado: (2022)

Exploring Alzheimer’s Disease Molecular Variability via Calculation of Personalized Transcriptional Signatures
por: Dagan, Hila, et al.
Publicado: (2020)

Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help
por: Medler, Terry R., et al.
Publicado: (2023)

Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes
por: Jubran, Maria R., et al.
Publicado: (2022)

ICOS is upregulated on T cells following radiation and agonism combined with radiation results in enhanced tumor control
por: Blair, Tiffany, et al.
Publicado: (2022)

Moving beyond the T cell synapse for combination neoadjuvant immunotherapy in head and neck cancer
por: Bell, R. Bryan, et al.
Publicado: (2022)

Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production
por: Alice, Alejandro F., et al.
Publicado: (2021)

Intratumoral injection of STING ligand promotes abscopal effect
por: Baird, Jason R, et al.
Publicado: (2014)

Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy
por: Flashner-Abramson, Efrat, et al.
Publicado: (2019)

Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
por: Crittenden, Marka R., et al.
Publicado: (2018)

OX40 and other immunoregulatory molecules are highly expressed on tumor infiltrating lymphocytes in oral, head and neck squamous cell carcinoma
por: Montler, Ryan, et al.
Publicado: (2014)

STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2017)

Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2018)

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma
por: Leidner, Rom, et al.
Publicado: (2021)

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
por: Young, Kristina H., et al.
Publicado: (2016)

Fluorescent tracking identifies key migratory dendritic cells in the lymph node after radiotherapy
por: Blair, Tiffany C, et al.
Publicado: (2022)

A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity
por: Zebertavage, Lauren, et al.
Publicado: (2019)

Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures
por: Vasudevan, Swetha, et al.
Publicado: (2021)

Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance
por: Couey, Marcus A., et al.
Publicado: (2019)

The Peripheral Myeloid Expansion Driven by Murine Cancer Progression Is Reversed by Radiation Therapy of the Tumor
por: Crittenden, Marka R., et al.
Publicado: (2013)

Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy
por: Baird, Jason, et al.
Publicado: (2015)

Overexpressed kinetochore genes are used by cancer cells as genome destabilizers and transformation catalysts
por: Aldwaik, Reem Kamal, et al.
Publicado: (2023)

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
por: Crittenden, Marka R., et al.
Publicado: (2016)

The paradox of radiation and T cells in tumors
por: Gough, Michael J., et al.
Publicado: (2022)

The Impact of the Myeloid Response to Radiation Therapy
por: Gough, Michael J., et al.
Publicado: (2013)

Heterogeneity of Gene Expression in Murine Squamous Cell Carcinoma Development—The Same Tumor by Different Means
por: Cohen, Noam, et al.
Publicado: (2013)

Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
por: Rabah, Nadin, et al.
Publicado: (2023)

The efficacy of a protective protocol for oral and maxillofacial surgery procedures in a COVID-19 pandemic area—results from 1471 patients
por: Alterman, Michael, et al.
Publicado: (2021)

Immunotherapy in head and neck squamous cell carcinoma: a narrative review
por: Sharon, Shay, et al.
Publicado: (2022)

Programmed cell death-1 blockade in combination with stereotactic radiation in an orthotopic mouse model of hepatocellular carcinoma
por: Friedman, David, et al.
Publicado: (2015)

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
por: Duhen, Rebekka, et al.
Publicado: (2021)

Role of the immunosuppressive microenvironment in immunotherapy
por: Tormoen, Garth W., et al.
Publicado: (2018)

The TAM family as a therapeutic target in combination with radiation therapy
por: Tormoen, Garth W., et al.
Publicado: (2017)

Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma
por: Gunderson, Andrew J., et al.
Publicado: (2019)

Anomalous Features of EMT during Keratinocyte Transformation
por: Geiger, Tamar, et al.
Publicado: (2008)

Improved efficacy of radiation in combination with TGFβ inhibition in a colorectal cancer mouse model
por: Young, Kristina H, et al.
Publicado: (2013)

Computational Surprisal Analysis Speeds-Up Genomic Characterization of Cancer Processes
por: Kravchenko-Balasha, Nataly, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8vuo20749mhv4hdaf9cl0s0c4c